The New York Academy of Sciences doesn't hold "investor conferences". You know that.
The results were to be discussed by the lead investigator of trial Dr. Linda Liau, who heads UCLA's Neuro Oncology Department, not a company investment spokesperson. You know that.
The audience was comprised largely of Physicians who were and are members of the New Academy of Sciences, they were impressed to say the least.
The results were astounding. At the time, I believe Astra Zeneca's lead cancer researcher congratulated NWBO personnel on the landmark results of this trial. You know that.
The slide you misquote concerned PFS endpoint no being longer a valid endpoint due to issues of pseudo progression; and in fact patients experiencing pseudo progression were "living longer". You know that.
The primary endpoint became OS overall survival - the "gold standard" for cancer trials. You know that.
This inconsequential minutia has been rehashed to death. Who else but compensated trolls would continue to bring these non-issues up discouraging new investment in a badly needed cancer treatment. Good god. You are a lost soul.
(Caution - horse shit below)
jeez flipper the NYC was not a science conference it was a presentation for everyone interested in investing in NWBO, what part of what FeMike said here is it that you don't get:
"Nobody is going to wait until the end of a presentation to act on a binary event when the first slide they see says "failed to meet primary endpoint". Doesn't matter what is said after that, people are immediately scrambling to exit their positions."
Femike is not disputing whether DCVAXL is working for patients or not, it is, that is why he is still invested and that is why I am still invested.
Heck you are ignorant
Market Data 
Markets 
AI
